Publications by authors named "Simon Chell"

Claim this Profile
T
The prolyl hydroxylase inhibitor GSK1120360A reduces early brain injury, but protection is not maintained in a neonatal rat model of hypoxic ischaemic encephalopathy.
Nicole M Jones, Anton D Nathanson, Simon Chell, Elena DeAngelis, Greg Whelan

Int J Dev Neurosci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines.
Kathryn Balmanno, Simon D Chell, Annette S Gillings, Shaista Hayat, Simon J Cook

Int J Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells.
David Qualtrough, Abderrahmane Kaidi, Simon Chell, Henry N Jabbour, Ann C Williams

Int J Cancer· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Simon Chell, Abderrahmane Kaidi, Ann Caroline Williams, Christos Paraskeva

Biochim Biophys Acta· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
Simon D Chell, Ian R Witherden, Richard R Dobson, Morganaden Moorghen, Andrew A Herman

Cancer Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis